Board Member
Prelude Therapeutics Inc (PRLD)Equibles does not estimate personal net worth.
Get an email with a short summary when Prelude Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get PRLD alertsKrishna Vaddi is recorded as Board Member and CEO at Prelude Therapeutics Inc (PRLD). The newest filing on record that lists Krishna Vaddi as Board Member and CEO at Prelude Therapeutics Inc (PRLD) is dated April 29, 2026. The proxy statement of Prelude Therapeutics Inc reports total compensation of $1,348,000 for Krishna Vaddi in fiscal 2025, including a base salary of $615,441. Disclosed compensation is on record for 7 fiscal years. Krishna Vaddi has spoken on 1 investor event across 1 company, most recently for Prelude Therapeutics Inc on September 16, 2026. Prelude Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prelude Therapeutics Inc includes Bryant D. Lim (CFO), Julian C. Baker (Board Member), Katina Dorton (Board Member) and 2 others.
“Yeah, so I think the trial is set up to really ask three fundamental questions, right, that based on what Peggy just described. Can we really see as a monotherapy, you know, significantly differentiated, meaningfully different hematological toxicity profile?”
Start not stated–present
Last confirmed April 29, 2026
Start not stated–present
Last confirmed April 29, 2026
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Prelude Therapeutics Inc (PRLD) | Chief Executive Officer | $615,441 | $1,348,000 |
| 2024 | Prelude Therapeutics Inc (PRLD) | Chief Executive Officer | $594,167 | $2,327,471 |
| 2023 | Prelude Therapeutics Inc (PRLD) | Chief Executive Officer | $572,667 | $2,641,789 |
| 2022 | Prelude Therapeutics Inc (PRLD) | Chief Executive Officer | $558,333 | $3,304,152 |
| 2021 | Prelude Therapeutics Inc (PRLD) | Chief Executive Officer | $544,192 | $7,042,814 |
| 2020 | Prelude Therapeutics Inc (PRLD) | Ph.D.^(^^3)^ Chief Executive Officer | $417,058 | $11,632,464 |
| 2019 | Prelude Therapeutics Inc (PRLD) | Chief Executive Officer | $315,000 | $2,079,400 |
